Navigation Links
Drug May Delay Nursing Home Placement for Dementia Patients

Publishing in the September issue of Alzheimer’s Disease and Associated Disorders researchers from the University of South Florida’s Louis de la Parte Florida Mental Health// Institute’s (FMHI) Department of Mental Health, Law and Policy and the School of Aging Studies report finding that treating dementia patients with cholinesterase inhibitors (ChE-Is) may delay placement into nursing homes and provide improved quality of life while helping preserve personal and societal resources.

“Dementia is a very debilitating condition,” said co-author Ross Andel of the USF School of Aging Studies and the Florida Alzheimer’s Disease Research Center. “It affects up to 10 percent of adults over 65 and can account for up to 70 percent of the long-term care, nursing home population. This study provided evidence that treatment with ChE-Is can delay nursing home placement by an average of three and a half months, possibly as a function of temporary stabilization of cognitive and functional abilities.”

According to the Alzheimer’s Association (http://www.alz.org), ChE-Is are designed to increase levels of acetylcholine, a chemical messenger involved in memory and thought processing. The drug, first approved by the FDA in 1993, is known by several trade names, including Aricept, Exelon and Razadyne http://www.alz.org/Resources/
TopicIndex/cholinesteraseinhibitors.asp

To carry out this study, researchers used records from the Florida Medicaid program to follow separate groups of patients over age 60 with dementia who were either taking or not taking ChE-Is and had not been placed in a nursing home.

“The group of patients who were already taking ChE-Is were significantly older and included more women,” said lead author Marion Becker of FMHI. “That those taking ChE-Is were placed in a nursing home more than three months later than those not taking the drug has implications not only for patients and their families, but for controlling the rising costs of Medicaid.”

Cost effectiveness is also a consideration when expensive drugs are used in the Medicaid system.

“The cost of the therapy can be off-set by the financial benefits that come with nursing home placement delay,” Becker added.

Source-Nwswise
SRM
'"/>




Related medicine news :

1. Smoking Delays Pregnancy
2. Delaying Parkinson’s Diseas
3. Lifestyle changes Can Delay the Onset Of Dementia
4. Lifestyle changes Can Delay the Onset Of Dementia
5. Lifestyle changes Can Delay the Onset Of Dementia
6. A Vitamin A Day May Delay The Life span Of HIV Patients
7. Delaying The Progression Of Alzheimer’s Disease
8. The Effects Of Delaying A Delivery Questioned
9. Drug to Delay the Onset of Arthritis
10. Delaying pregnancy may lessen life expectancy of the child
11. In Early Epilepsy Delay in medications Recommended
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... 20, 2017 , ... In his newly appointed role as ... Ph.D., recently accepted the distinguished Sun Corridor Export Award for his company’s global ... and 16 other businesses from Pima, Pinal, and Maricopa counties in Arizona, and ...
(Date:6/20/2017)... ... June 20, 2017 , ... Total Security Integrated Systems, ... as the partner of choice by Amtrak to fulfill several projects in various ... and long-distance intercity service in the contiguous United States. Security Executives at the ...
(Date:6/20/2017)... ... June 20, 2017 , ... John D'Eri, CEO of Rising Tide ... Adult Autism Award during the Autism Society of America 's 49th annual ... Daniel Jordan Fiddle Foundation (DJFF) was founded in 2002 as the nation's first ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... the patient’s bedside, would like to officially welcome Anthony Stanowski, DHA, FACHE to ... Dr. Stanowski whose insight and expertise in healthcare will provide invaluable direction for ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... June 9, 2017 AirXpanders, Inc. (ASX: AXP) ... the design, manufacture, sale and distribution of the AeroForm® ... progress of its commercial roll-out in the ... more than one hundred (100) medical institutions and health ... offers a needle-free alternative for women who choose reconstructive ...
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
Breaking Medicine Technology: